A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age
Public ClinicalTrials.gov record NCT05900154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 1, OPEN-LABEL, AGE-DESCENDING, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE (RSVpreF) IN CHILDREN 2 TO <18 YEARS OF AGE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn about the safety and immune activity of the vaccine (called RSVpreF) in children 2 to \<18 years of age. This study will identify the dose level to be used in Phase 2/3 trials in this age cohort. All participants will receive one injection of RSVpreF. This study has four study visits, two in-clinic and two telehealth visits. Blood samples will be collected for testing. This study is about 6 months long for each participant and will be conducted in the United States.
Study identification
- NCT ID
- NCT05900154
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2023 (Actual)
- Primary completion
- Feb 29, 2024 (Actual)
- Completion
- Feb 29, 2024 (Actual)
- Last update posted
- Mar 6, 2025
2023 – 2024
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham - School of Medicine | Birmingham | Alabama | 35233 | — |
| Stanford University Medical Center | Palo Alto | California | 94304 | — |
| Peninsula Research Associates | Rolling Hills Estates | California | 90274 | — |
| Bio-Medical Research LLC | Miami | Florida | 33144 | — |
| Velocity Clinical Research, Sioux City | Sioux City | Iowa | 51106 | — |
| Velocity Clinical Research, New Orleans | Metairie | Louisiana | 70006 | — |
| Velocity Clinical Research, Omaha | Omaha | Nebraska | 68134 | — |
| Rochester Clinical Research, LLC | Rochester | New York | 14609 | — |
| Duke Vaccine And Trials Unit | Durham | North Carolina | 27703 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Senders Pediatrics | South Euclid | Ohio | 44121 | — |
| Velocity Clinical Research, Providence | East Greenwich | Rhode Island | 02818 | — |
| Innovo Research - Austin Regional Clinic | Austin | Texas | 78726 | — |
| Velocity Clinical Research, Austin | Austin | Texas | 78759 | — |
| Velocity Clinical Research, Salt Lake City | West Jordan | Utah | 84088 | — |
| Seattle Children's - Building Cure | Seattle | Washington | 98101 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05900154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05900154 live on ClinicalTrials.gov.